Enable breadcrumbs token at /includes/pageheader.html.twig

Pharmaceutical Help Against Covid

Pfizer Inc., New York, New York, was awarded a $1,959,999,848 modification (P00005) to contract W58P05-22-C-0001 for the oral therapeutic Paxlovid. Work will be performed in New York, New York, with an estimated completion date of Dec. 31, 2028. Fiscal 2021 Coronavirus Preparedness Response and Relief Supplemental Appropriations Act funds in the amount of $1,959,999,848 were obligated at the time of the award. U.S. Army Contracting Command, New Jersey, is the contracting activity.

Comments

The content of this field is kept private and will not be shown publicly.

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.